Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma

Clinical trial NCT00193973 · COMPLETED

Trial details

NCT number: NCT00193973
Sponsor: Trans Tasman Radiation Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Central Nervous System Lymphoma

Start date: 2001-07-01
Primary completion: 2008-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.